Targeted antitumor effect induced by hTERT promoter mediated ODC antisense adenovirus

Molecular Biology Reports

Volumn 37, Issue 7, 2010, Pages 3239-3247

  Wang, Wei ^a   Jin, Bin ^b   Li, Wei ^a   Xu, Chun Xiao ^a   Cui, Fu Ai ^a   Liu, Bin ^a   Yan, Yun Fei ^a   Liu, Xian Xi ^a   Wang, Xiu Li ^c  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Ornithine decarboxylase; Target gene therapy; Telomerase reverse transcriptase promoter; Tumor cell

Indexed keywords

ADENOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN; ORNITHINE DECARBOXYLASE; TELOMERASE REVERSE TRANSCRIPTASE;

ANTINEOPLASTIC ACTIVITY; ANTISENSE THERAPY; ANTISENSE VECTOR; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR CLONING; PROMOTER REGION; PROTEIN EXPRESSION; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

ADENOVIRIDAE; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; COLLAGEN; DRUG COMBINATIONS; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME ASSAYS; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; HUMANS; LAMININ; LUCIFERASES; NEOPLASM INVASIVENESS; ORNITHINE DECARBOXYLASE; PROMOTER REGIONS, GENETIC; PROTEOGLYCANS; RNA, ANTISENSE; TELOMERASE; TRANSDUCTION, GENETIC;

ADENOVIRIDAE;

EID: 77956953248     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-009-9908-5     Document Type: Article

References (38)

1. L Vergani G Mascetti C Nicolini 1998 Effects of polyamines on higher-order folding of in situ chromatin Mol Biol Rep 25 4 237 244 1:CAS:528:DyaK1MXhs12jtg%3D%3D 10.1023/A:1006937212430 9870614 (Pubitemid 28560255)
2. RA Hillary AE Pegg 2003 Decarboxylases involved polyamine biosynthesis and their inactivation by nitric oxide Biochim Biophys Acta 11 1-2 161 166
3. V Bruce Grossie Jr K Nishioka 1998 Effect of ornithine in parenteral nutrition regimens on difluoromethylornithine-induced platelet suppression and changes in tumor polyamine content Cancer Invest 16 3 160 165 10.3109/07357909809050030
4. T Thomas TJ Thomas 2003 Polyamine metabolism and cancer J Cell Mol Med 7 2 113 126 1:CAS:528:DC%2BD3sXmvFGjsro%3D 10.1111/j.1582-4934.2003.tb00210.x 12927050
5. BH Devens RS Weeks MR Burns CL Carlson MK Brawer 2000 Polyamine depletion therapy in prostate cancer Prostate Cancer Prostatic Dis 3 4 275 279 1:CAS:528:DC%2BD3MXht1SitrY%3D 10.1038/sj.pcan.4500420 12497077
6. FL Meyskens Jr EW Gerner 1999 Development of difluoromethylornithine (DFMO) as a chemoprevention agent Clin Cancer Res 5 945 951 1:CAS:528: DyaK1MXjslKlt7c%3D 10353725
7. Y Zhang XX Liu B Zhang HY Hu L Gong 2005 Antitumor effect of antisense ODC adenovirus on human prostate cancer cells Prostate Cancer Prostatic Dis 8 3 280 286 1:CAS:528:DC%2BD2MXpslalt7k%3D 10.1038/sj.pcan.4500808 16103892 (Pubitemid 43118067)
8. L Gong CY Jiang B Zhang HY Hu W Wang XX Liu 2006 Adenovirus-mediated expression of both antisense ornithine decarboxylase and S-adenosylmethionine decarboxylase induces G1 arrest in HT-29 cells J Biochem Mol Biol 39 6 730 736 1:CAS:528:DC%2BD28XhtlWgu7fP 17129409
9. B Zhang XX Liu Y Zhang CY Jiang HY Hu L Gong M Liu QS Teng 2006 Polyamine depletion by ODC-AdoMetDC antisense adenovirus impairs human colorectal cancer growth and invasion in vitro and in vivo J Gene Med 8 980 989 1:CAS:528:DC%2BD28XpsFKisrc%3D 10.1002/jgm.936 16783835 (Pubitemid 44282994)
10. CE Thomas A Ehrhardt MA Kay 2003 Progress and problems with the use of viral vectors for gene therapy Nat Rev Genet 4 5 346 358 1:CAS:528: DC%2BD3sXjtlaksr4%3D 10.1038/nrg1066 12728277 (Pubitemid 36538359)
11. Verma IM, Somia N (1997) Gene therapy-promises, problems and prospects. Nature 389(6648):239-242
12. WF Anderson 1998 Human gene therapy Nature 392 6679 Suppl 25 30 1:CAS:528:DyaK1cXjtVyltb0%3D 9579858
13. J-S Song 2004 Activity of the human telomerase catalytic subunit (hTERT) gene promoter could be increased by the SV40 enhancer Biosci Biotechnol Biochem 68 8 1634 1639 1:CAS:528:DC%2BD2cXnsVKnt7o%3D 10.1271/bbb.68.1634 15322345 (Pubitemid 39260292)
14. CW Greider EH Blackburn 1985 Identification of a specific telomere terminal transferase activity in Tetrahymena extracts Cell 43 405 413 1:CAS:528:DyaL28Xot12itQ%3D%3D 10.1016/0092-8674(85)90170-9 3907856
15. NW Kim MA Piatyszek KR Prowse, et al. 1994 Specific association of human telomerase activity with immortal cells and cancer Science 23266 2011 2015 10.1126/science.7605428
16. A Shervington V Pawar S Menon, et al. 2009 The sensitization of glioma cells to cisplatin and tamoxifen by the use of catechin Mol Biol Rep 36 5 1181 1186 1:CAS:528:DC%2BD1MXjvFaqu74%3D 10.1007/s11033-008-9295-3 18581255
17. I Braunstein O Cohen-Barak C Shachaf, et al. 2001 Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells Cancer Res 15 5529 5536
18. JS Song HP Kim KW Lee 2003 Adenovirus-mediated suicide gene therapy using the human telomerase catalytic subunit(hTERT) gene promoter induced apoptosis of ovarian cancer cell line Biosci Biotechnol Biochem 67 2344 2350 1:CAS:528:DC%2BD3sXps1emurc%3D 10.1271/bbb.67.2344 14646192 (Pubitemid 39251635)
19. AS Majumdar DE Hughes SP Lichtsteiner, et al. 2001 The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters Gene Ther 8 568 578 1:CAS:528:DC%2BD3MXis1emurc%3D 10.1038/sj.gt.3301421 11319624 (Pubitemid 32409532)
20. M Henriksson B Luscher 1996 Proteins of the Myc network: essential regulators of cell growth and differentiation Adv Cancer Res 68 109 182 1:CAS:528:DyaK28Xktlegu7w%3D 10.1016/S0065-230X(08)60353-X 8712067
21. J Gu M Andreeff JA Roth B Fang 2002 hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity Gene Ther 9 1 30 37 1:CAS:528:DC%2BD38XhtV2iu70%3D 10.1038/sj.gt.3301619 11850720
22. TC He S Zhou LT da Costa J Yu KW Kinzler B Vogelstein 1998 A simplified system for generating recombinant adenoviruses Proc Natl Acad Sci USA 95 5 2509 2514 1:CAS:528:DyaK1cXhslehsLw%3D 10.1073/pnas.95.5.2509 9482916 (Pubitemid 28145972)
23. L Prevec BS Christie KE Laurie MM Bailey FL Graham KL Rosenthal 1991 Immune response to HIV-1 gag antigens induced by recombinant adenovirus vectors in mice and rhesus macaque monkeys J Acquir Immune Defic Syndr 4 568 576 1:STN:280:DyaK3M3hsl2itA%3D%3D 1902514
24. D Wei Z Tang S Chen 2000 Construction of recombinant adenovirus vector containing mIL-12 using the method of homogenous recombination in bacteria and its expression in vitro with high efficient Chin J Biochem Mol Biol 16 716 721 1:CAS:528:DC%2BD3MXjvVOktw%3D%3D
25. HY Hu XX Liu CY Jiang, et al. 2005 Ornithine decarboxylase gene is overexpressed in colorectal carcinoma World J Gastroenterol 11 15 2244 2248 1:CAS:528:DC%2BD2MXksVylsr4%3D 15818733
26. XX Liu L Wang Y Lin, et al. 2000 Ornithine decarboxylase activity and its gene expression are increased in benign hyperplastic prostate Prostate 43 83 87 1:CAS:528:DC%2BD3cXjtFajur4%3D 10.1002/(SICI)1097-0045(20000501)43:2<83:: AID-PROS2>3.0.CO;2-O 10754523 (Pubitemid 30220610)
27. PR Lowenstein RJ Mandel WD Xiong K Kroeger MG Castro 2007 Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions Curr Gene Ther 7 5 347 360 1:CAS:528:DC%2BD1cXhsVKjtQ%3D%3D 10.2174/156652307782151498 17979681 (Pubitemid 47595777)
28. HC Esther FP Kathleen KB Bouker 2000 Tp53 gene therapy: a key to modulating resistance to anticancer therapies? Mol Med Today 6 9 358 364 10.1016/S1357-4310(00)01767-6
29. HC Kirch S Ruschen D Brockmann, et al. 2002 Tumor-specific activation of hTERT-derived promoters by tumor suppressive E1A-mutants involves recruitment of p300/CBP/HAT and suppression of HDAC-1 and defines a combined tumor targeting and suppression system Oncegene 21 52 7991 8000 1:CAS:528:DC%2BD38XoslGlsbw%3D 10.1038/sj.onc.1205965 (Pubitemid 35430610)
30. JW Shay Y Zou E Hiyama WE Wright 2001 Telomerase and cancer Hum Mol Genet 10 7 677 685 1:CAS:528:DC%2BD3MXjt1ajsLk%3D 10.1093/hmg/10.7.677 11257099
31. MN Helder G Bea A Wisman, et al. 2002 Telomerase and telomeres: from basic biology to cancer treatment Cancer Invest 20 1 82 101 1:CAS:528: DC%2BD38XitFOmsr8%3D 10.1081/CNV-120000370 11855380
32. T Komata Y Kondo T Kanzawa, et al. 2001 Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter Cancer Res 61 15 5796 5802 1:CAS:528:DC%2BD3MXlvVCgtbk%3D 11479218
33. I Horikawa PL Cable C Afshari JC Barrett 1999 Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene Cancer Res 59 4 826 830 1:CAS:528:DyaK1MXht1Sju7k%3D 10029071 (Pubitemid 29086735)
34. Y Li J Wang J Liu, et al. 2008 Clinical analysis of thoracoscopic lobectomy: a report of 40 cases Zhonghua Wai Ke Za Zhi 46 6 405 407 18785570
35. K Hiyama E Hiyama S Ishioka, et al. 1995 Telomerase activity in small-cell and non-small-cell lung cancer J Natl Cancer Inst 87 895 901 1:CAS:528:DyaK2MXmvFCgsbw%3D 10.1093/jnci/87.12.895 7666478
36. H Sahara T Nakanishi M Kitamoto, et al. 1995 Telomerase activity in human liver tissue: comparison between chronic liver disease and hepatocelluar carcinoma Cancer Res 55 2734 2736
37. C Mayeur G Veuillet M Michaud F Raul HM Blottiere F Blachier 2005 Effects of agmatine accumulation in human colon carcinoma cells on polyamine metabolism, DNA synthesis and the cell cycle Biochim Biophys Acta 1745 1 111 123 1:CAS:528:DC%2BD2MXns1Wjt70%3D 10.1016/j.bbamcr.2004.12.004 16085059 (Pubitemid 41111974)
38. T Thomas DT Kiang 1987 Additive growth-inhibitory effects of DL-alpha-difluoromethylornithine and antiestrogens on MCF-7 breast cancer cell line Biochem Biophys Res Commun 148 1338 1345 1:CAS:528:DyaL1cXjtFE%3D 10.1016/S0006-291X(87)80279-6 3120713